boehringer ingelheim glp-1 glp-1-dual-agonist-survodutide-weightloss-obesity-overweight-improvement Boehringer-Zealand drug leads to 16.6%

Hitting every major muscle group (legs, back, chest, shoulders, arms, core) is enough for most people to preserve and build strength during a deficit

If GLP-1 agonists show superior neuroprotective benefits, this could challenge the traditional treatment paradigm and support initiating therapy with GLP-1 agonists in selected patients. GLP-1 agonists have demonstrated mechanisms that include reducing neuroinflammation, enhancing cerebral glucose metabolism, and improving synaptic plasticity, Wu added

External links [edit] "Glucagon Receptor Family: GLP-1"

Common side effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation